Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$24.65

0.36 (1.48%)

09:28
01/11/19
01/11
09:28
01/11/19
09:28

Audentes accelerated approval in 2020 a possibility, says H.C. Wainwright

Potential accelerated approval for Audentes Therapeutics's AT132 during 2020 is "viable, highly desirable, and imminently pursuable," H.C. Wainwright analyst Debjit Chattopadhyay tells investors in a research note titled "AT132 Accelerated Approval During 2020 Is Well Within the Realm of Possibilities." While management is not guiding to it, the data thus far supports the underlying premise for accelerated approval, says Chattopadhyay. He believes the Q3 of 2019 update from additional patients is likely to establish AT132 "not only as the first but best in class gene therapy" for X-linked myotubular myopathy. The analyst keeps a Buy rating on Audentes Therapeutics with a $33 price target.

BOLD Audentes Therapeutics
$24.65

0.36 (1.48%)

11/07/18
11/07/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Freeport McMoRan (FCX) downgraded to Underperform from Sector Perform at RBC Capital with analyst Stephen Walker saying he points to the company's premium valuation ahead of what he expects to be a decline in 2019 production. 2. Zillow (Z, ZG) downgraded to Sell from Hold at Zelman and to Negative from Neutral at Susquehanna. 3. Mindbody (MB) downgraded to Neutral from Buy at UBS and Roth Capital as well as to Neutral from Overweight at JPMorgan. 4. Frontier Communications (FTR) downgraded to Sell from Neutral at UBS with analyst Batya Levi saying Frontier's free cash flow remains under pressure. 5. Audentes downgraded to Market Perform from Outperform at William Blair with analyst Raju Prasad saying increased competition in Pompe disease is giving him pause. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/26/18
JPMS
11/26/18
INITIATION
Target $35
JPMS
Overweight
Audentes Therapeutics initiated with an Overweight at JPMorgan
JPMorgan analyst Anupam Rama started Audentes Therapeutics with an Overweight rating and $35 price target. The stock has pulled 40% since early October, which represents an attractive long-term entry point, Rama tells investors in a research note. He believes the "de-risked nature" of the known clinical data for gene therapy lead assets AT132 in X-Linked Myotubular Myopathy and AT342 in Crigler-Najjar Syndrome "goes underappreciated" at current share levels.
01/11/19
GUGG
01/11/19
UPGRADE
GUGG
Buy
Audentes Therapeutics upgraded to Buy from Neutral at Guggenheim
01/11/19
GUGG
01/11/19
UPGRADE
Target $35
GUGG
Buy
Audentes Therapeutics upgraded to Buy at Guggenheim on positive AT132 outlook
As reported earlier, Guggenheim analyst Whitney Ijem upgraded Audentes Therapeutics to Buy from Neutral with a price target of $35 at the conclusion of the JPMorgan Healthcare conference this week. The analyst says that he is "incrementally more positive" on the company's A132 program after the meeting, anticipating "productive regulatory and data updates in the near term." Ijem further expects 2019 to be a year of of "pipeline progress" for Audentes Therapeutics now that the Pompe program is "back on track" and ahead of more details about a larger neuromuscular indication.

TODAY'S FREE FLY STORIES

08:45
01/24/19
01/24
08:45
01/24/19
08:45
General news
Treasury Action: yields ticked up from lows »

Treasury Action: yields…

PAA

Plains All American

$23.35

-0.05 (-0.21%)

, APRN

Blue Apron

$1.34

-0.03 (-2.19%)

08:45
01/24/19
01/24
08:45
01/24/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

PAA

Plains All American

$23.35

-0.05 (-0.21%)

APRN

Blue Apron

$1.34

-0.03 (-2.19%)

AXDX

Accelerate Diagnostics

$16.56

-0.22 (-1.31%)

APHA

Aphria

$6.92

-0.15 (-2.12%)

FOSL

Fossil

$17.16

0.24 (1.42%)

APA

Apache

$31.00

-0.5 (-1.59%)

XON

Intrexon

$7.75

-0.28 (-3.49%)

TRXC

TransEnterix

$2.63

(0.00%)

FAZ

Direxion Financial Bear 3x

$10.88

-0.03 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 05

    Feb

  • 10

    Feb

08:45
01/24/19
01/24
08:45
01/24/19
08:45
General news
FX Action: The dollar »

FX Action: The dollar was…

HAFC

Hanmi Financial

$21.73

(0.00%)

08:44
01/24/19
01/24
08:44
01/24/19
08:44
Hot Stocks
Hanmi Financial announces 1.5M share repurchase program »

Hanmi Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAH

Platform Specialty Products

$10.90

-0.15 (-1.36%)

08:44
01/24/19
01/24
08:44
01/24/19
08:44
Conference/Events
Platform Specialty Products to hold a conference call »

Conference call to to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZPN

Aspen Technology

$89.08

0.22 (0.25%)

08:44
01/24/19
01/24
08:44
01/24/19
08:44
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$31.57

-1.18 (-3.60%)

08:43
01/24/19
01/24
08:43
01/24/19
08:43
Hot Stocks
Breaking Hot Stocks news story on American Airlines »

American Airlines says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

IIIN

Insteel

$20.34

-0.81 (-3.83%)

08:42
01/24/19
01/24
08:42
01/24/19
08:42
Upgrade
Insteel rating change  »

Insteel upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAT

Waters

$229.46

25.94 (12.75%)

08:42
01/24/19
01/24
08:42
01/24/19
08:42
Recommendations
Waters analyst commentary  »

Waters price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 30

    Jan

TLGT

Teligent

$1.69

-0.11 (-6.11%)

08:41
01/24/19
01/24
08:41
01/24/19
08:41
Hot Stocks
Teligent receives FDA approval for Clobetasol Propionate Ointment ANDA »

Teligent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRWD

Ironwood

$12.41

-0.32 (-2.51%)

, AGN

Allergan

$160.81

3.045 (1.93%)

08:41
01/24/19
01/24
08:41
01/24/19
08:41
Upgrade
Ironwood, Allergan rating change  »

JPMorgan upgrades…

IRWD

Ironwood

$12.41

-0.32 (-2.51%)

AGN

Allergan

$160.81

3.045 (1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 18

    May

  • 28

    May

ATU

Actuant

$21.90

-0.15 (-0.68%)

08:41
01/24/19
01/24
08:41
01/24/19
08:41
Hot Stocks
Breaking Hot Stocks news story on Actuant 

Actuant trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$108.64

0.4 (0.37%)

08:40
01/24/19
01/24
08:40
01/24/19
08:40
Recommendations
Citrix analyst commentary  »

Citrix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLX

Deluxe

$43.31

0.08 (0.19%)

08:40
01/24/19
01/24
08:40
01/24/19
08:40
Earnings
Deluxe sees FY19 adjusted EPS slightly increasing over 2018, consensus $5.51 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SHLX

Shell Midstream

$19.73

0.19 (0.97%)

08:40
01/24/19
01/24
08:40
01/24/19
08:40
Hot Stocks
Shell Midstream increases quarterly dividend 4.7% to 40c per share »

Shell Midstream announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZPN

Aspen Technology

$89.08

0.22 (0.25%)

08:39
01/24/19
01/24
08:39
01/24/19
08:39
Recommendations
Aspen Technology analyst commentary  »

Aspen Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$4.78

-0.21 (-4.21%)

, MRK

Merck

$75.43

-0.42 (-0.55%)

08:39
01/24/19
01/24
08:39
01/24/19
08:39
Hot Stocks
Inovio reports second full remission from head & neck cancer after treatment »

Inovio (INO) announced…

INO

Inovio

$4.78

-0.21 (-4.21%)

MRK

Merck

$75.43

-0.42 (-0.55%)

BMY

Bristol-Myers

$49.92

0.21 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 28

    Jan

  • 01

    Feb

  • 16

    Feb

  • 28

    Feb

  • 11

    Apr

  • 18

    May

  • 20

    May

F

Ford

$8.34

-0.17 (-2.00%)

08:38
01/24/19
01/24
08:38
01/24/19
08:38
Periodicals
Hard Brexit to cost Ford up to $800M in 2019 alone, Sky News reports »

A hard Brexit will cost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

DLX

Deluxe

$43.31

0.08 (0.19%)

08:38
01/24/19
01/24
08:38
01/24/19
08:38
Earnings
Deluxe sees Q1 adjusted EPS $1.05-$1.15, two est. $1.29 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

PCG

PG&E

$8.03

0.3 (3.88%)

08:37
01/24/19
01/24
08:37
01/24/19
08:37
Recommendations
PG&E analyst commentary  »

PG&E bankruptcy not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLX

Deluxe

$43.31

0.08 (0.19%)

08:37
01/24/19
01/24
08:37
01/24/19
08:37
Earnings
Deluxe reports Q4 adjusted EPS $1.54, consensus $1.47 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

WTBA

West Bancorp

$20.09

0.17 (0.85%)

08:36
01/24/19
01/24
08:36
01/24/19
08:36
Earnings
Breaking Earnings news story on West Bancorp »

West Bancorp reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

AAL

American Airlines

$31.57

-1.18 (-3.60%)

08:36
01/24/19
01/24
08:36
01/24/19
08:36
Hot Stocks
American Airlines says '2018 was a challenging year' »

Says: "We enter 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

UTX

United Technologies

$117.08

5.85 (5.26%)

08:36
01/24/19
01/24
08:36
01/24/19
08:36
Recommendations
United Technologies analyst commentary  »

United Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBH

First Mid-Illinois Bancshares

$33.31

-0.13 (-0.39%)

08:35
01/24/19
01/24
08:35
01/24/19
08:35
Earnings
First Mid-Illinois Bancshares reports Q4 EPS 62c, consensus 73c »

Reports Q4 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.